HRT without hot flashes: 12-week symptom tracker
Rate how troublesome each symptom was over the past 7 days, using 0 to 3: 0 = not a problem, 1 = mild, 2 = moderate, 3 = severe. Record the actual date at each snapshot. This is our own unvalidated recording scale, not a medical score. For UTIs, record clinician-diagnosed episodes over the past 28 days at each snapshot, separately from urgency; note episode dates between reviews. A blank means "not recorded," not zero.

Use a landscape print layout or more than one page rather than shrinking or clipping the table.

Symptom	Week 0 (before starting)	Week 4	Week 12	Notes for my clinician
Actual recording date				
Sleep (0–3)				
Night sweats (0–3)				
Mood or irritability (0–3)				
Brain fog or focus (0–3)				
Joint or muscle aches (0–3)				
Vaginal dryness or pain with sex (0–3)				
Urinary urgency (0–3)				
Clinician-diagnosed UTIs in past 28 days (count; also note episode dates)				
Energy (0–3)				
Side effects, bleeding or refill gaps				
How to read it: compare each symptom-rating row to week 0, one row at a time. Don't add rows together — they measure different things. Keep UTI counts and episode dates as a separate history; neither this score nor a 12-week log can establish whether recurrent-UTI prevention is working.

Worked example (made up): Sleep went 3 → 2 → 1. Vaginal dryness went 3 → 2 → 1. Brain fog stayed 2 → 2 → 2. That tells a clear story: the sleep and dryness ratings fell by 2 points each; the fog rating didn't change. Bring exactly that to your review and describe what changed in daily life. There is no validated 1-point success threshold for this tracker.

Use the same plain-language goal before and after. And don't use the tracker to change or stop medicine yourself — bring it to your prescriber. You can also use our [HRT response log](https://thehrtindex.com/hrt-response-log/). Don't wait for week 4 or 12 to seek advice about unexplained bleeding, a possible infection or another concerning symptom.

Use and privacy
Use this for treatment agreed with your clinician, not to decide that you should start HRT. Your clinician's review schedule takes precedence over these editorial snapshots. Fill the static file privately; it does not submit answers or generate a medical result. Keep the completed copy somewhere appropriate for sensitive health information.

The 0–3 symptom ratings refer to the past 7 days; UTI counts refer to the past 28 days at each snapshot and remain separate. Record dates of other episodes between snapshots. Do not add ratings, compute a percentage response, compare unequal observation periods or treat a one-point change as a validated success threshold. A zero count is not a blank, and no count proves that prevention worked.

[The Menopause Society, 2022 hormone therapy statement](https://menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf) · [NICE review guidance](https://www.nice.org.uk/guidance/ng23/chapter/Recommendations) · [AUA GSM guideline](https://www.auanet.org/guidelines-and-quality/guidelines/genitourinary-syndrome-of-menopause).

This is an original editorial record, not a reproduced clinical guideline table, diagnosis, prescription decision or treatment plan. The HRT Index is not a healthcare provider. Talk to your clinician before changing treatment.